APA (7th ed.) Citation

P, J., L, N., S, R., R, S., PA, D., & M, E. (2004). Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis. Lancet, 364(9450), 2021. https://doi.org/10.1016/s0140-6736(04)17514-4

Chicago Style (17th ed.) Citation

P, Jüni, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, and Egger M. "Risk of Cardiovascular Events and Rofecoxib: Cumulative Meta-analysis." Lancet 364, no. 9450 (2004): 2021. https://doi.org/10.1016/s0140-6736(04)17514-4.

MLA (9th ed.) Citation

P, Jüni, et al. "Risk of Cardiovascular Events and Rofecoxib: Cumulative Meta-analysis." Lancet, vol. 364, no. 9450, 2004, p. 2021, https://doi.org/10.1016/s0140-6736(04)17514-4.